Table 1. Details of the patients included in the immunological analysis of this study.
| Disease severity (n) | Mild | Moderate | Severe | |
|---|---|---|---|---|
| (n=17) | (n=32) | (n=14) | ||
| Age (median, SD) | 53±14.5 | 58±12.6 | 61.5±10 | |
| Sex, % (n) | Female | 35.3 (6) | 31.2 (10) | 50 (7) |
| Male | 64.7 (11) | 68.5 (22) | 50 (7) | |
| Ethnicity, % (n) | Caucasian | 83.3% (14) | 78.1% (25) | 87.7% (12) |
| Asian | 11.7% (2) | 12.5% (4) | 14.3% (2) | |
| Black | 5.9% (1) | 6.3% (2) | 0 (0) | |
| Missing data | 0 (0) | 3.1% (1) | 0 (0) | |
| BMI, kg/m2, % (average, SD) | Healthy | 7.6% (22.3±0.57) | 12.5% (23.75±0.5) | 14.3% (23±0) |
| Overweight | 35.3% (26.6±1.5) | 28.1% (27±1.39) | 28.6% (28.75±0.5) | |
| Obese | 35.3% (32.8±1.47) | 46.9% (32.7±2.46) | 28.6% (35±2.1) | |
| Extremely obese | 11.8% (61±28.2) | 9.38% (46.3±6.02) | 28.6% (46±7.34) | |
| Missing data | 0 | 3.1% | 0 | |
| Comorbidity % (n) | None | 47.1% (8) | 43.75% (14) | 14.3% (2) |
| Heart disease | 23.5% (4) | 15.6% (5) | 14.3% (2) | |
| T1DM | 0 (0) | 3.1% (1) | 7.14% (1) | |
| T2DM | 5.88% (1) | 12.5% (4) | 14.3% (2) | |
| Hypertension | 17.65 (3) | 18.75% (6) | 50% (7) | |
| Chronic lung disease | 5.88% (1) | 21.88% (7) | 50% (7) | |
| Kidney disease | 5.88 (1) | 9.37% (3) | 14.3% (2) | |
| Mental health | 0 (0) | 6.25% (2) | 14.3% (2) | |
| Cancer | 5.88% (1) | 3.1% (1) | 7.14 (1) | |
| Asthma | 5.88% (1) | 0 (0) | 14.3% (2) | |
| Total obesity | 47.1% (8) | 53.1% (17) | 57.1% (8) | |
| Other | 47.1% (8) | 28.1% (9) | 50% (7) | |
| Hospital stay (average days, SD) | 3.3±1.99 | 7.8±5.16 | 12±6.67 | |
|
Ongoing symptoms at 3 months (n, %) |
None | 3 (17.65%) | 8 (25%) | 2 (14.3%) |
| Dyspnoea | 7 (41.2%) | 15 (47%) | 9 (64.3%) | |
| Excessive fatigue | 5 (29.4%) | 12 (37.5%) | 9 (64.3%) | |
| Muscle weakness | 3 (17.65) | 7 (22%) | 5 (35.7%) | |
| Sleeping difficulties | 3 (17.65) | 6 (18.75%) | 8 (57%) | |
| Psychiatric | 2 (11.8%) | 8 (25%) | 6 (42.9%) | |
| Anosmia | 2 (11.8%) | 4 (12.5%) | 3 (21.4%) | |
| Chest pain | 2 (11.8%) | 6 (18.75%) | 2 (14.3%) | |
| Cough | 2 (11.8%) | 4 (12.5%) | 1 (7.14%) | |
| Other | 5 (29.4%) | 4 (12.5%) | 3 (21.4%) | |